Effects of Dexmedetomidine on Basic Cardiac Electrophysiology in Adults; a Descriptive Review and a Prospective Case Study DOI Creative Commons
Reino Pöyhiä, Teija Nieminen,

Ville W. T. Tuompo

et al.

Pharmaceuticals, Journal Year: 2022, Volume and Issue: 15(11), P. 1372 - 1372

Published: Nov. 8, 2022

Dexmedetomidine (DEX) is a commonly used sedative agent with no or minimal effects on breathing. DEX may also be beneficial in myocardial protection. Since the mechanisms of cardiac are not well known, we carried out descriptive review and examined electrical conduction prospective controlled manner. For review, clinical studies exploring protection published between 2020-2022 were explored. A case study included 11 consecutive patients at median (range) age 48 (38-59), scheduled for elective radiofrequency ablation paroxysmal atrial fibrillation. bolus dose 1 µg/kg given 15 min was followed by continuous infusion 0.2-0.7 µg/kg/h. Direct intracardiac electrophysiologic measurements, hemodynamics oxygenation measured before after bolus. Experimental show that protects heart both via stabilizing electrophysiology reducing apoptosis autophagy cell injury. The evidence shows provides during different surgeries. In study, increased corrected sinus node recovery time, prolongated atrioventricular (AV) nodal refractory period cycle length producing AV Wenckebach retrograde block. has putative role organ against hypoxic, oxidative reperfusion slows down firing prolongs refractoriness.

Language: Английский

Effects of Dexmedetomidine on Cognitive Function, Oxidative Stress and Brain Protection in Patients Undergoing Craniocerebral Surgery DOI Open Access
Yan Fu,

Jin Zhu

Actas Españolas de Psiquiatría, Journal Year: 2024, Volume and Issue: 52(1), P. 19 - 27

Published: Feb. 5, 2024

Background: The protective mechanism of dexmedetomidine on the brains patients undergoing craniocerebral surgery remains unclear. aim this study was to examine impact cognitive function, oxidative stress, and brain protection in such patients. Methods: Fifty-four who underwent at our hospital from January 2020 June 2023 were retrospectively selected as subjects. They divided into two groups: control group (n = 27) 27), based different auxiliary anesthesia protocols. Patients received before induction, using a midline intravenous pump assist anesthesia, while an equivalent amount normal saline. remaining induction maintenance protocols consistent for both groups. Cognitive function assessed Mini Mental State Examination (MMSE) 1 day after Oxidative stress indicators, including malondialdehyde (MDA), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) levels serum groups, measured enzyme-linked immunosorbent assay (ELISA). Additionally, changes postoperative injury namely neuron-specific enolase (NSE) central nervous system-specific protein (S100β), detected compared Concurrently, adverse reactions recorded Results: MMSE scale scores groups 24 hours significantly lower than those surgery. However, notably higher group, with statistically significant difference (p < 0.05). One hour surgery, MDA, GSH-Px, SOD elevated pre-surgery levels. Yet, exhibited comparison these differences NSE S100β markedly preoperative demonstrated incidence complications 7.41% (2/27), indicating decreasing trend 18.52% (5/27) group. did not reach statistical significance (χ2 1.477, p 0.224). Conclusion: Dexmedetomidine-assisted can effectively enhance mitigate facilitate overall recovery intervention exhibits favorable safety profile no reported serious reactions, establishing it relatively safe reliable approach.

Language: Английский

Citations

1

Dexmedetomidine-mediated improvement of perioperative neurocognitive disorders by miR-184-3p-mediated NLRP3 DOI
Fumou Deng, Bin Zhou, Shenglan Zhang

et al.

Brain Research, Journal Year: 2024, Volume and Issue: 1842, P. 149051 - 149051

Published: June 1, 2024

Language: Английский

Citations

1

Effects of esketamine combined with dexmedetomidine on postoperative delirium and quality of recovery in elderly patients undergoing thoracoscopic radical lung cancer surgery: a randomized controlled trial DOI Open Access

Cong-Li Zhang,

Yan Yan, Yang Zhang

et al.

CNS Spectrums, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 10

Published: Nov. 20, 2024

This study aimed to investigate the effects of esketamine (Esk) combined with dexmedetomidine (Dex) on postoperative delirium (POD) and quality recovery (QoR) in elderly patients undergoing thoracoscopic radical lung cancer surgery.

Language: Английский

Citations

1

Impact of Dexmedetomidine-Based Opioid-Sparing Anesthesia on Opioid Use After Minimally Invasive Repair of Pectus Excavatum: A Prospective Randomized Controlled Trial DOI Open Access
Min-Ju Kim, Jaewon Huh, Hoon Choi

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(23), P. 7264 - 7264

Published: Nov. 29, 2024

Background: Opioid-sparing anesthesia (OSA) using dexmedetomidine has gained attention as an alternative to opioid-based (OBA) due its potential reduce opioid consumption and the associated side effects. This study aimed investigate effect of dexmedetomidine-based OSA on postoperative pain intensity, consumption, recovery outcomes in patients undergoing a minimally invasive repair pectus excavatum. Methods: Eighty-four excavatum were randomized either group, receiving dexmedetomidine, or OBA remifentanil. The primary outcome was total amount analgesics administered within 24 h postoperatively. secondary included intensity analgesic over 48 h, outcomes, intraoperative hemodynamics, opioid-related complications. Results: OFA group reported significantly reduced morphine-equivalent dose (55.4 ± 31.1 mg vs. 80.2 26.7 mg, p < 0.001) lower VAS scores at (3.9 1.5 5.4 2.1, 0.001). Pain lower, 1–6, 6–24, 24–48 after surgery. Recovery times hemodynamics comparable between groups, with no significant differences Conclusions: Dexmedetomidine-based effectively reduces use without compromising hemodynamic stability. These findings support viable OBA, particularly

Language: Английский

Citations

1

Effects of Dexmedetomidine on Basic Cardiac Electrophysiology in Adults; a Descriptive Review and a Prospective Case Study DOI Creative Commons
Reino Pöyhiä, Teija Nieminen,

Ville W. T. Tuompo

et al.

Pharmaceuticals, Journal Year: 2022, Volume and Issue: 15(11), P. 1372 - 1372

Published: Nov. 8, 2022

Dexmedetomidine (DEX) is a commonly used sedative agent with no or minimal effects on breathing. DEX may also be beneficial in myocardial protection. Since the mechanisms of cardiac are not well known, we carried out descriptive review and examined electrical conduction prospective controlled manner. For review, clinical studies exploring protection published between 2020-2022 were explored. A case study included 11 consecutive patients at median (range) age 48 (38-59), scheduled for elective radiofrequency ablation paroxysmal atrial fibrillation. bolus dose 1 µg/kg given 15 min was followed by continuous infusion 0.2-0.7 µg/kg/h. Direct intracardiac electrophysiologic measurements, hemodynamics oxygenation measured before after bolus. Experimental show that protects heart both via stabilizing electrophysiology reducing apoptosis autophagy cell injury. The evidence shows provides during different surgeries. In study, increased corrected sinus node recovery time, prolongated atrioventricular (AV) nodal refractory period cycle length producing AV Wenckebach retrograde block. has putative role organ against hypoxic, oxidative reperfusion slows down firing prolongs refractoriness.

Language: Английский

Citations

7